Stockreport

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Generation Bio Co. - Common stock  (GBIO) 
PDF -  Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases -  Lead target and [Read more]